Skip to main
MEDP
MEDP logo

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 9%
Hold 64%
Sell 9%
Strong Sell 18%

Bulls say

Medpace Holdings is poised for robust growth, with expected passthrough revenues projected to increase by 200-300 basis points in the second half of the year compared to elevated levels in the second quarter. The company has reported strong performance in the first quarter, highlighted by a higher request-for-proposal (RFP) volume, which underscores demand for its services. Furthermore, Medpace anticipates a favorable book-to-bill ratio, expected to return to above 1.15x in the third quarter, indicating strong order flow and a healthy pipeline for future revenue.

Bears say

Medpace Holdings has reported a concerning trend in its backlog cancellations, which increased to levels currently at or above the upper range of what the company considers normal, although there was a slight decrease in recent quarters. The company's future revenue growth projections for Direct Service remain uncertain, as management states it is too early to quantify potential outcomes, despite projecting a stable performance in 2026. Updated adjusted EBITDA estimates for 2025 and 2026 reflect an increase to $521 million and $550 million, respectively; however, this is accompanied by ongoing hiring in direct service costs and a decline in passthroughs anticipated for 2026, indicating potential financial strain and operational inefficiencies.

Medpace Holdings (MEDP) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 9% advise Selling, and 18% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 11 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $465.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $465.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.